GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Administrative Core

$247,747
Anil K Rustgi · University Of Pennsylvania · P30 · FY2017 · DK

Administrative Core

$247,747
Gary D. Wu · University Of Pennsylvania · P30 · FY2021 · DK

Experimental Therapeutics

$247,662
Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2013 · CA

High-throughput analysis of pancreatic cancer mutations

$247,571
Scott E Kern · Johns Hopkins University · R01 · FY2012 · CA

High-throughput analysis of pancreatic cancer mutations

$247,569
Scott E Kern · Johns Hopkins University · R01 · FY2011 · CA

The role of the Kras4A isoform in epithelial carcinogenesis

$247,562
Allan Balmain · University Of California, San Francisco · R01 · FY2014 · CA

ENGINEERING T CELLS FOR PANCREATIC CANCER

$247,486
Helen E Heslop · Baylor College Of Medicine · P01 · FY2014 · CA

Clinical protocols for the treatment of gastrointestinal cancer

$247,314
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Platform for Structure-Function Studies of Adhesion GPCRs implicated in Cancer

$247,298
Said Eshaghi · Scripps Research Institute, The · R21 · FY2014 · CA

Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia

$247,298
Enrique Saez · Scripps Research Institute, The · R21 · FY2013 · CA

The role of FoxM1 in pancreatic cancer

$247,275
Andrei L Gartel · University Of Illinois At Chicago · R21 · FY2009 · CA

TARGETING OXIDATIVE STRESS IN HUMAN PANCREATIC CANCER

$247,253
Robert T Dorr · University Of Arizona · P01 · FY2010 · CA

Cytotoxic Gonadotropin Releasing Hormone Derivatives

$247,245
Gonex, Inc. · R41 · FY2002 · CA

SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK

$247,225
Dominique S Michaud · Brown University · R21 · FY2010 · CA

Implementation of DPYD gene sequencing as an adaptation of pharmacogenetic screening to prevent severe toxicity during cancer treatment with fluoropyrimidine chemotherapy

$247,178
Gabriel Arne Brooks · Dartmouth College · P20 · FY2025 · GM

Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancer

$247,063
Stephen J Pandol · University Of California Los Angeles · P01 · FY2022 · CA

Cytotoxic Gonadotropin Releasing Hormone Derivatives

$247,052
Gonex, Inc. · R41 · FY2003 · CA

Clinical Research Core

$246,971
Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2015 · CA

Tissue and Pathology Core

$246,964
Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2014 · CA

MULTIDISCRIPLINARY TRAINING IN DIGESTIVE DISEASES

$246,951
Mayo Clinic Coll Of Medicine, Rochester · T32 · FY2002 · DK

SENSITIZATION OF THERAPEUTIC-RESISTANT PANCREATIC CANCER BY CANCER CELL-SPECIFIC DRUG DELIVERY

$246,950
Cedars-Sinai Medical Center · · FY2018 · Defense Health Agency

Impact of Neutrophil Extracellular Traps (NETs) on the Pancreatic Tumor Microenvironment

$246,840
Brian A Boone · West Virginia University · P20 · FY2021 · GM

MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis

$246,820
State University New York Stony Brook · R01 · FY2005 · CA

MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis

$246,820
State University New York Stony Brook · R01 · FY2004 · CA

Genetic Approaches to Pancreatic Cancer Progression

$246,779
Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA